096760.KS
JW Holdings Corporation

Healthcare · Drug Manufacturers - Specialty & Generic · valued as of 2026-11-03 · statements 2025-12-31

Average Intrinsic Value

981.39M USD

Market Cap

224.21M USD

Margin of Safety

77.1%

Intrinsic / Market Ratio

4.38×

Projections, not exact values. Intrinsic Values are projected from each company's past reports. They show which stocks look cheap compared with the others, not exactly what a stock is worth.

How Each Value Is Built

The screener's three formulas on the reported figures. Each card reads the same way: the value as a sum of numbered terms, each term's calculation opened under it, from the reported figures to the value. The list ranks companies by their plain average over the market cap.

EPV + Growth

1.20B USD

what the normal year's earnings are worth for ever, plus growth that pays

Profit

569.74M USD

15 years of cash the shareholders can take out, and the equity left at year 15

FCFF

1.17B USD

15 years of cash for shareholders and lenders, less what is owed

Intrinsic Value

981.39M USD

the plain average of the three, uncapped, as the screener averages them

Intrinsic Value

981.39M USD

from the sum above

Market Cap

224.21M USD

the price on the date above times the shares

Intrinsic Value ÷ Market Cap

4.38×

the ratio the screener ranks by; Margin of Safety +77.1% (1 − Market Cap ÷ Intrinsic Value)

Each card below builds one of the three values from the reported years.

Earnings power value plus growth: 1.20B USD
What the normal year's operating profit after tax is worth if it lasts for ever, plus what the new investment adds beyond its cost, less the net debt that comes before the shareholders (or plus the net cash).
①EPV (earnings power value)1.17B USD
−②Net Debt Today164.72M USD
+③Growth Value196.55M USD
=Value1.20B USD

EPV of the Operations (NOPAT over WACC)

1.17B USD

Net debt today

-164.72M USD

Growth Value

+196.55M USD

Value

1.20B USD

①EPV (earnings power value)

1.17B USD

②Net Debt Today

164.72M USD

③Growth Value

196.55M USD

Market value

Market Cap224.21M USD

The price on the date above times the shares.

Value vs market

Margin of Safety+81.4%

1 minus the market cap as a share of the value.

Profit value: today's value of the shareholders' equity, from the cash it can pay them (FCFE): 569.74M USD
Fifteen years of free cash flow to equity (FCFE), each brought to today at the cost of equity, plus the equity at year 15 brought to today.
①Present Value of the 15 Years of FCFE324.54M USD
+②Equity at Year 15, Today245.20M USD
=Value569.74M USD
FCFE: the net income left for the shareholders once the business keeps what next year's growth needsEquity reinvestment: the part of the year's net income kept in the business to grow the next year; below zero, capital the business releases to the shareholdersPresent value of the FCFEColoured bars show the FCFE, grey bars the equity reinvestment. With a positive equity reinvestment the two stacked are the year's normalized income; with a negative one the grey is below zero, capital the business releases, and the normalized income is the FCFE plus that negative amount. Shaded, years 6 to 10: the growth falling to its long-run rate and the ROE on new investment falling to the cost of equity. Axes linear.

①Present Value of the 15 Years of FCFE

324.54M USD

②Equity at Year 15, Today

245.20M USD

Market value

Market Cap224.21M USD

The price on the date above times the shares.

Value vs market

Margin of Safety+60.6%

1 minus the market cap as a share of the value.

FCFF value: today's value of the shareholders' equity, from the cash the firm can pay its shareholders and lenders (FCFF): 1.17B USD
Fifteen years of free cash flow to the firm (FCFF), each brought to today at the WACC, plus the invested capital at year 15 brought to today, less the net debt today (or plus the net cash).
①Present Value of the 15 Years of FCFF776.07M USD
+②Invested Capital at Year 15, Today558.81M USD
−③Net Debt Today164.72M USD
=Value1.17B USD
FCFF: the NOPAT left for the shareholders and the lenders once the business reinvests what next year's growth needsReinvestment: the part of the year's NOPAT put back into the business to grow the next year; below zero, capital the business releasesPresent value of the FCFFColoured bars show the FCFF, grey bars the reinvestment. With a positive reinvestment the two stacked are the year's NOPAT; with a negative one the grey is below zero, capital the business releases, and the NOPAT is the FCFF plus that negative amount. Shaded, years 6 to 10: the growth falling to its long-run rate and the ROIC on new investment falling to the WACC. Axes linear.

①Present Value of the 15 Years of FCFF

776.07M USD

②Invested Capital at Year 15, Today

558.81M USD

③Net Debt Today

164.72M USD

Market value

Market Cap224.21M USD

The price on the date above times the shares.

Value vs market

Margin of Safety+80.8%

1 minus the market cap as a share of the value.

The Rates and the Capital the Values Read

The WACC and the cost of equity each value is discounted at, the book value and the net debt each starts from, and the seven quality metrics, from the same run.

WACC: 6.34%
Cost of Equity =Risk-Free Rate 4.50%+Beta 0.58×Market Risk Premium 6.00%= 7.96%

The yearly return the shareholders require for the risk they carry; it is the rate that brings their future cash to today.

Tax Rate for WACC =Tax Provision 20.03M USDPretax Income 100.42M USD= 19.94%

The tax the interest saves.

Interest Expense =EBIT 114.24M USD−Pretax Income 100.42M USD= 13.82M USD

The interest the company paid: EBIT is the profit before tax plus the interest.

Cost of Debt =Interest Expense 13.82M USDTotal Debt 231.81M USD×(1 − Tax Rate for WACC 19.94%)= 4.77%

What the lenders are paid a year after the tax the interest saves.

Debt Weight =Total Debt 231.81M USDMarket Cap + Total Debt 224.21M USD + 231.81M USD= 50.83%

The part of the capital the lenders put in, at market value.

WACC =Equity Weight 49.17%×Cost of Equity 7.96%+Debt Weight 50.83%×Cost of Debt 4.77%= 6.34%

Weighted average cost of capital: the yearly return the shareholders and the lenders together require, weighted by what each puts in; the rate that brings the firm's future cash to today.

Book value and net debt today
Both from the balance sheet of the newest quarter, 2026-06-30.

Total Assets 828.19M USD − Total Liabilities 408.96M USD = Book Value Today 419.23M USD

Total Debt 231.81M USD − Cash and Short-Term Investments 67.09M USD = Net Debt Today 164.72M USD

The book value is what Profit starts from and what stands when a projection is not made; the book value plus the net debt is what FCFF starts from; the net debt comes off Greenwald's and FCFF's values before the shareholders.

Quality metrics
Read beside the value, never a condition for it: every company is valued, and a filter in the list is the reader's choice.
MetricFrom
Share dilutionShares Today ÷ Shares Two Years Back − 1-2.3%at most 5%passes69,190,827 / 70,839,158
Accrual quality(Operating Cash Flow − Net Income) ÷ Total Assets8.8%at least -10.0%passes(113.94M USD − 40.73M USD) ÷ 828.19M USD
Price to bookMarket Cap ÷ Book Value Today0.53×at most 3×passes224.21M USD ÷ 419.23M USD
Operating marginOperating Income ÷ Revenue17.3%above 10.0%passes116.88M USD ÷ 674.96M USD
Revenue growthRevenue ÷ Revenue a Year Before − 111.5%above 10.0%passes674.96M USD / 605.56M USD
Net cash(Cash − Total Debt) ÷ Market Cap-81.7%above -30%does not pass(48.70M USD − 231.81M USD) ÷ 224.21M USD
Operating efficiencyOperating Income ÷ Gross Profit34.2%above 25.0%passes116.88M USD ÷ 342.14M USD

Market Data

The provider's ratios and the analysts' consensus beside the argument; none of them enters a value.

Share price

4289.28 KRW

Enterprise value

906.80B KRW

the provider's own figure

EV / EBITDA

3.92×

Price / book

—

the provider's book

Price / earnings

—

Return on equity

26.8%

the provider's figure, not this page's

Profit margin

8.3%

Revenue growth

16.7%

Analyst target, mean

—

Analysts

—

opinions in the consensus

Financial Statements

The annual lines the screener holds, year by year, in USD at each period's rate; the figures this valuation read are in its calculation above.

USD2022202320242025
Income statement

Revenue

686.68M727.01M605.56M674.96M

Gross profit

317.68M349.50M296.89M342.14M

Operating income

90.03M113.89M100.12M116.88M

EBITDA

operating income before depreciation and amortisation

108.35M101.95M157.85M144.63M

Pretax income

56.39M41.82M107.88M100.42M

Net income

17.59M14.90M42.72M40.73M

Normalized income

net income without one-off items, as the data provider prints it; Profit's line when printed

22.43M44.45M29.81M42.34M

R&D

26.33M26.43M26.66M34.01M
Balance sheet, year end

Total assets

919.44M921.43M853.12M857.09M

Total liabilities

654.74M648.23M497.44M443.14M

Shareholders' equity

the equity the parent's shareholders own, as printed, without minority interest; the book value the values read is total assets less total liabilities, in Book Value and Net Debt above

84.98M97.11M156.58M185.85M

Total debt

438.45M434.44M297.34M250.35M

Cash and equivalents

48.02M57.89M30.04M50.00M

Net PP&E

fixed assets after depreciation

283.75M317.68M341.93M340.46M

Working capital

current assets less current liabilities

-165.08M-182.76M-29.68M-38.86M
Cash flow

Operating cash flow

82.94M87.98M66.78M113.94M

Capital expenditure

paid out, so below zero

-55.69M-66.82M-24.36M-38.08M

Depreciation and amortisation

31.87M34.64M28.03M30.38M

Free cash flow

operating cash flow plus capital expenditure

27.26M21.16M42.42M75.86M